Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$25,000.00
Mar 19, 2024
Not-for-profit organization or charity
Investigating effects of anthropometric differences on respirator performance
1015430
Advances exploratory research under the New Beginnings Initiative
$100,000.00
Sep 3, 2018
For-profit organization
CTO for Clinical Trials program design and planning consultation and advisory services
912771
The aim of the PHRI CTO project is to bridge the gap between lab research and clinical research for SMEs in Ontario, to bring their innovation goals closer to commercialization. Through our strong research methodology knowledge, understanding of clinical application and knowledge of the regulatory environment, PHRI can successfully map out a clinical trial strategy that is efficient and effective in positioning the SME product to be clinically relevant.
$5,040.00
Jun 11, 2018
N/A